CJC-1295 (No DAC) + Ipamorelin (Blend)
GHRH Analog + Ghrelin Mimetic Blend | Growth Hormone Pathway Research
₱2600.00₱2100.00
BUY NOW |
|---|
Third-party Tested | Free Shipping Nationwide | COA Verified |
Active Batch | Purity |
IPA-CJC-SL2Q25-5 | > 99.8% |
All products are third-party tested by our manufacturer before release and are submitted again to an independent third-party laboratory upon arrival in the Philippines. This additional testing helps verify identity, purity, heavy metals, residual solvents, microbial safety, and overall batch quality before distribution. If independent testing shows purity below 99%, we offer a money-back guarantee.
CJC-1295 No DAC + Ipamorelin is an investigational peptide blend commonly discussed in research settings for its potential relevance to growth-hormone secretagogue pathways, recovery-related models, sleep-associated protocols, and body-composition research. This blend typically combines CJC-1295 without DAC, a short-acting growth hormone–releasing hormone analog, with Ipamorelin, a growth hormone secretagogue often studied for its selective ghrelin-receptor activity.
Unlike metabolic peptides such as tirzepatide or retatrutide, CJC-1295 No DAC + Ipamorelin is not designed around GLP-1, GIP, or glucagon receptor activity. Instead, scientific interest centers on growth hormone pulse signaling, GH/IGF-1 axis research, recovery-related experimental models, sleep-timing protocols, and broader body-composition investigation.
CJC-1295 and Ipamorelin remain investigational in many contexts and should not be marketed as treatments for fat loss, muscle growth, anti-aging, sleep disorders, injury recovery, or hormone deficiency. Both compounds are also listed under the World Anti-Doping Agency’s prohibited framework: WADA names CJC-1295 among GHRH analogues and Ipamorelin among growth hormone secretagogues.
Potential research interests observed or discussed
Growth hormone pulse research
CJC-1295 No DAC and Ipamorelin are commonly discussed in experimental models involving pulsatile growth hormone release, secretagogue activity, and GH-axis signaling.
GH/IGF-1 axis investigation
Because the blend is often studied in relation to growth hormone signaling, research interest frequently extends to IGF-1 response, endocrine feedback, and related pathway analysis.
Sleep and nighttime protocol interest
Ipamorelin and CJC-1295 No DAC are often presented in research-oriented protocols involving pre-sleep timing, overnight hormone-pulse modeling, and recovery-associated sleep research.
Recovery-oriented experimental models
This blend is frequently discussed in peptide research communities for experimental models involving training recovery, tissue stress response, and restoration-related pathways.
Body-composition research
CJC-1295 No DAC + Ipamorelin is often studied in broader investigational contexts related to lean-mass support, fat-loss protocol interest, metabolic signaling, and performance-related research discussions.
Selective secretagogue interest
Ipamorelin is often described as a growth hormone secretagogue with research interest around selective ghrelin-receptor activity and GH-release signaling.
Short-acting protocol interest
CJC-1295 No DAC is commonly differentiated from DAC-containing versions because it is discussed as a shorter-acting GHRH analog, making it a frequent subject in pulse-oriented research protocols.
Blend-format research interest
The 5 mg / 5 mg blend format is commonly discussed because it combines a GHRH analog with a GHS-style peptide, allowing researchers to evaluate combined secretagogue-pathway interest in a single formulation.
Limitations and risks observed or discussed
Limited human clinical evidence
Much of the public discussion around CJC-1295 No DAC + Ipamorelin extends beyond the level of controlled human clinical evidence available. More well-designed human trials are needed before safety, dosing, or effectiveness claims can be established.
Not an FDA-approved medication
CJC-1295 No DAC + Ipamorelin should not be represented as an FDA-approved treatment for anti-aging, fat loss, muscle growth, sleep, injury recovery, or hormone optimization. Reports on peptide regulation continue to note the distinction between compounded or research-market availability and formal FDA approval.
Unknown long-term safety profile
Because controlled long-term human data are limited, the long-term safety profile, interaction risks, appropriate populations, and contraindications are not fully established.
Hormone-axis concerns
Because this blend is discussed in relation to GH and IGF-1 signaling, inappropriate use may raise concerns around endocrine disruption, abnormal hormone levels, glucose metabolism, fluid retention, or other hormone-related effects.
Possible risks from unregulated products
Products sold online as “research chemicals” may carry risks related to contamination, inaccurate concentration, mislabeling, sterility issues, or lack of regulated manufacturing oversight. Recent reporting has highlighted concerns around unapproved peptide products, inconsistent quality, and limited human safety data.
Athlete compliance concerns
CJC-1295 and Ipamorelin are prohibited in sport under WADA’s peptide hormone and growth hormone secretagogue categories, creating significant compliance concerns for tested athletes.
Claims may exceed the evidence
Many online claims around “anti-aging,” “fat loss,” “muscle growth,” “sleep improvement,” or “recovery enhancement” go beyond what has been proven in controlled human trials.
Human use requires medical and regulatory caution
Because this blend remains investigational in many contexts, it should only be handled under appropriate research conditions and should not be used as a substitute for approved medical care.
Website-safe closing line
CJC-1295 No DAC + Ipamorelin 5 mg / 5 mg blend is scientifically interesting for growth hormone secretagogue, recovery-related, sleep-timing, and body-composition research, but human safety and effectiveness remain insufficiently established. This blend is not approved for human clinical use as a treatment and should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.
